Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01359111 · ClinicalTrials.gov registry record · Phase 1
Performance and Safety Evaluation of an Intradermal Delivery Device
A Phase 1 study, sponsored by PATH.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01359111 is a Phase 1 study that has completed, run by PATH. The registered enrollment target is 20 participants.
The verdict
NCT01359111, a Phase 1 study, has completed, sponsored by PATH.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether an investigational vaccine delivery device (the ID adapter) can safely and precisely inject liquid into the intradermal layer of the skin.
Interventions
- DEVICE PATH ID Adapter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01359111
The ClinicalTrials.gov registry entry for NCT01359111 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PATH, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PATH ID Adapter is the first listed.
NCT01359111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01359111 about?
NCT01359111 is a clinical study titled "Performance and Safety Evaluation of an Intradermal Delivery Device". The purpose of this study is to evaluate whether an investigational vaccine delivery device (the ID adapter) can safely and precisely inject liquid into the intradermal layer of the skin.
What is the current status of trial NCT01359111?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01359111?
The interventions under investigation include: PATH ID Adapter (DEVICE).
Who is sponsoring clinical trial NCT01359111?
This trial is sponsored by PATH, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.